| S Ashley Willard, PHARMD | |
|
2495 Old Taylor Rd Unit 206, Oxford, MS 38655-5181 | |
| (210) 286-0690 | |
| Not Available |
| Full Name | S Ashley Willard |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 2495 Old Taylor Rd Unit 206, Oxford, Mississippi |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194248518 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | E-13928 (Mississippi) | Primary |
| 183500000X | Pharmacist | 42426 (Tennessee) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| S Ashley Willard, PHARMD 2495 Old Taylor Rd Unit 206, Oxford, MS 38655-5181 Ph: () - | S Ashley Willard, PHARMD 2495 Old Taylor Rd Unit 206, Oxford, MS 38655-5181 Ph: (210) 286-0690 |
News Archive
ArQule, Inc. and Daiichi Sankyo Co., Ltd. today announced the expansion of their research, development and license agreement for the discovery of novel kinase inhibitors in the field of oncology. This expanded agreement establishes a third therapeutic target, with an option for a fourth, in the field of oncology, and it includes a two-year extension based on the application of the proprietary ArQule Kinase Inhibitor Platform (AKIP™) technology.
Louisiana Tech University will receive over $1.4 million in grant funding from NASA's Experimental Program to Stimulate Competitive Research, through an award to the Louisiana Board of Regents, to serve as the lead institution for research that investigates how high doses of space radiation during extended duration space missions will affect astronauts.
The size of glass used for serving wine can influence the amount of wine drunk, suggests new research from the University of Cambridge, funded by the National Institute of Health Research (NIHR).
Abraxis BioScience, Inc. today announced that its randomized registrational Phase 3 clinical trial comparing ABRAXANE® (protein-bound paclitaxel) with Taxol® (paclitaxel) injection, both in combination with carboplatin, met the study's primary endpoint by demonstrating that ABRAXANE showed a significant improvement in overall response rate as compared to Taxol, in the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC), as assessed by independent radiologist review.
› Verified 6 days ago
Mrs. Desiree Wilson, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1912 Jackson Ave W, Oxford, MS 38655 Phone: 662-238-3427 | |
Marti Elizabeth White, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1808 University Ave, Oxford, MS 38655 Phone: 662-513-0894 | |
Charles Frederick Wurth, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 518 Hwy 331, Oxford, MS 38655 Phone: 662-236-2296 | |
Charles Inman, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1808 University Ave, Oxford, MS 38655 Phone: 662-513-0894 Fax: 662-513-4606 | |
Dr. Larry Brent Bishop, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1808 University Ave, Oxford, MS 38655 Phone: 662-513-0894 | |
Cassandra Sullivan, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 502 Woodland Hills Dr, Oxford, MS 38655 Phone: 662-236-1478 | |
Brent A Sutherland, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2159 S Lamar Blvd, Oxford, MS 38655 Phone: 662-236-2222 |